相关实验视频

Updated: Jun 18, 2026

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

Published on: June 15, 2016

降低MD-1调控与减少细胞表面CD180表达在CLL中有关

Kurtis Edwards¹, Maria Manoussaka², Uzma Sayed¹

¹School of Life Sciences, University of Westminster, London, UK.

Leukemia research

|June 19, 2024

概括

慢性淋巴细胞白血病 (CLL) 中B细胞的CD180表达减少与生存率低下有关. 这项研究揭示CD180下调源于低MD-1水平,而不是转录性变化,影响细胞表面受体的稳定性.

科学领域:

免疫学免疫学免疫学
分子生物学分子生物学
在瘤学瘤学.

背景情况:

CD180是一种类似收费的受体,通常在含有MD-1分子的B细胞中大量存在.
在慢性淋巴细胞白血病 (CLL) 中,CD180表达是可变的,通常是减少的,与患者生存率较差相关.
了解在CLL中CD180下调背后的机制至关重要.

研究的目的:

调查CLL中CD180细胞表面表达减少的原因.
分析CD180和MD-1表达在CLL细胞中的RNA和蛋白质水平.

主要方法:

在CLL细胞和正常B细胞中对CD180和MD-1RNA水平的定量分析.
使用流细胞计量评估细胞表面和细胞内CD180蛋白表达.
将CLL患者样本与健康对照样本之间的表达模式进行比较.

主要成果:

在CLL细胞和正常B细胞中,CD180RNA水平相似.
尽管表面CD180很低,但细胞内CD180蛋白很丰富,表明翻译发生.
与正常B细胞相比,CLL细胞中的MD-1RNA水平明显较低.

结论:

在CLL中CD180细胞表面下调并不是由于转录减少.
由MD-1水平降低引起的CD180的缺陷后翻译稳定是可能的机制.
这一发现为CLL病原和潜在的治疗点提供了洞察力.

关键词:

CD180 CD180 CD180 CD180 CD180 CD180 CD180 CD180 CD180 CD180 CD180 CD180 CD180 CD180 CD180 CD180 CD180 CD180 CD180 CD180 CD180 CD180 CD180 CD180 CD180 CD180 CD180 CD180 CD180 CD180 CD180 CD180 CD180 CD180 CD180 CD2 CD2 CD2 CD2 CD2 CD2 CD3 CD2 CD2 CD2 CD3 CD4 CD2 CD2 CD2 CD2 CD3 CD2 CD2 CD2 CD3 CD4 CD2 CD2 CD2 CD2 CD2 CD3 CD2 CD2 CD2 CD2 CD3 CD4 CD2 CD2 CD2 CD3 CD2 CD2 CD2 CD2 CD3 CD2 CD4 CD2 CD2 CD2 CD3 CD2 CD2 CD4 CD2 CD2 CD2 CD3 CD2 CD2 CD4 CD2 CD2 CD2 CD2 CD2 CD3 CD2 CD2 CD2 CD2 CD2 CD3 CD2 CD2 CD2 is what is what is what is what is what is what is 在 CLL CLL 中.这是一个MD-1MD-1.收费类受体的收费类受体

更多相关视频

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

Published on: July 20, 2016

Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking

Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking

Published on: October 23, 2019

相关概念视频

Receptor Downregulation in MVBs

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...